Search results for Drug Updates

Biotech Insights - Spring 2026

Regulatory Overview: Post-Approval Changes to Marketed Drugs - The popularity of GLP-1s have brought post-approval changes to New Drug Applications (NDAs) to centerstage. Recently...

Regulatory Overview: Post-Approval Changes to Marketed Drugs

The popularity of GLP-1s have brought post-approval changes to New Drug Applications (NDAs) to centerstage. Recently, the FDA approved Wegovy in tablet form, offering an alternativ...

<![CDATA[Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request ]]>

Tiny Chains, Big Changes? What FDA’s Latest Actions Mean for Peptide Compounding

Key Takeaways: FDA will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to discuss seven peptides for potential inclusion on the 503A bulks list. A...

Old Drugs, New Tricks: FDA’s Drug Repurposing Initiative

By Charles D. Snow & Kalie E. Richardson —

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Datroway]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo]]>

New Pill Could Change Plaque Psoriasis Treatment

THURSDAY, April 2, 2026 — Folks with severe plaque psoriasis often have to choose between convenient pills that don’t work very well or highly effective injections that come with t...

<![CDATA[FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection ]]>

New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes

THURSDAY, April 16, 2026 — New anti-amyloid drugs approved to treat Alzheimer’s disease have no clinically meaningful positive effects for patients, a major evidence review has co...

Healthcare Authority Newsletter - May 2026 #3

News Briefs - High Court Won't Hear Drug Manufacturer Price Negotiation Appeal - The Supreme Court declined to hear an appeal from six drug manufacturers that wanted the court to r...

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review

WEDNESDAY, April 29, 2026 — The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon...

One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says

THURSDAY, April 16, 2026 — A widely used anxiety medication is being pulled from shelves due to "failed dissolution specifications," the U.S. Food and Drug Administration (FDA) sa...

FDA To Review Whether To Allow More Access To Certain Peptides

FRIDAY, April 17, 2026 — The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding phar...

U.S. Plans Tariffs up to 100% on Some Brand-Name Drugs

TUESDAY, April 7, 2026 — The United States is planning new tariffs on some name-brand medicines. The move could affect drug prices and how medicines are made. Officials say tariffs...

FDA to Consider Lifting Restrictions on Numerous Compounded Peptides

On April 16, 2026, the U.S. Food & Drug Administration (FDA) announced it will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23 and 24, 2026, to discuss pe...

New drug Cychlorphine poses extreme overdose risks

A dangerous synthetic drug, referred to as Cychlorphine, has reportedly been detected in illegal drugs seized in Texas and at least 9 other states, according to the White House Off...

The FDA Cracks Down on Tavneos

The FDA Cracks Down on Tavneos Anonymous (not verified) Thu, 04/30/2026 - 14:18 pharmagather item url The FDA Cracks Down on Tavneos pha...

Health Ministry brings CNS drug Pregabalin under Schedule H1 to prevent misuse

Following the notification, Pregabalin will now be regulated under the stricter provisions of Schedule H1, instead of the existing Schedule H, under the Drugs and Cosmetics Rules,...

Less-Dangerous Painkillers, Gabapentinoids, Still Have High Risk For Drug Interactions

TUESDAY, April 21, 2026 — People prescribed gabapentinoid painkillers, such as gabapentin (Gralise, Neurontin, Gabarone, Relgaabi), gabapentin enacarbil (Horizant), or pregabalin (...

マイナポータルの「薬」が改善　当日中に薬や処方せん情報を反映

デジタル庁は25日、「マイナポータル」の「薬」画面を改善した。従来は、前月までに薬局や医療機関で受け取った薬の情報を確認できたが、リニューアルにより、直近100日以内に受け取った薬や処...

New Weight Loss Pill Gets Approval But FDA Seeks More Safety Data

WEDNESDAY, April 15, 2026 — The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo, ac...

<![CDATA[Pharmaceutical Executive Daily: Idvynso Receives FDA Approval]]>